Pricing Log in Create free account

Editas Medicine, Inc. (EDIT) vs Adherex Technologies Inc. (FENC)

Editas Medicine, Inc. and Adherex Technologies Inc. are both Biotechnology companies. Editas Medicine, Inc. and Adherex Technologies Inc. are of similar size ($374.7M and $362.9M). Adherex Technologies Inc. grew revenue faster over the last twelve months: 77.8% against 20.8%. Adherex Technologies Inc. has the higher net margin (−5.49% vs −157.3%) and the lower return on invested capital (−58.9% vs 0.00%). Across the 16 metrics below, Adherex Technologies Inc. leads on 10 and Editas Medicine, Inc. on 6.

Valuation

Metric EDIT FENC Biotechnology median
P/E n/m n/m 8.50
P/S 5.96 5.82 9.71
P/B 2.66 8.12 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.15 5.44 9.21
Earnings yield (31.91%) (1.24%) (33.15%)
Free cash flow yield (42.90%) (0.59%) (25.50%)

Profitability

Metric EDIT FENC Biotechnology median
Gross margin 100.00% 93.73% 65.16%
Operating margin (161.39%) (1.90%) 0.00%
Net margin (157.32%) (5.49%) 0.00%
Free cash flow margin (255.88%) (3.44%) 0.00%
Return on equity (118.82%) (18.58%) (56.36%)
Return on assets (33.02%) (5.39%) (48.04%)
Return on invested capital 0.00% (58.89%) 0.00%

Growth

Metric EDIT FENC Biotechnology median
Revenue growth (TTM) 20.83% 77.83% 6.02%
EPS growth (last fiscal year) 37.50% (2,087.50%) 30.26%
Revenue growth, 5-year CAGR (14.89%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDIT FENC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.19 5.85 4.72
Net debt to EBITDA 0.94 6.02 0.96

Dividend

Metric EDIT FENC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EDIT FENC Biotechnology median
Market cap 374.74m 362.94m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack